ContributorsPublishersAdvertisers

Author Correction: A phase I clinical trial for [I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma

Nature.com
 2022-01-19

Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-43880-6, published online 20 May 2019. The original version of this article contained an error in the 95% confidence intervals calculated for the second and third courses of 131I-mIBG. As a result, in the Results section under the subheading 'Response evaluation',. "Eight patients received a...

www.nature.com

Comments / 0

Comments / 0